Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F'(2) (vol 37, pg 1504, 1996)

被引：0
|
作者：
Juweid, ME
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 1996年 / 37卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1765 / 1765
页数：1
相关论文
共 15 条
  • [1] Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')(2)
    Juweid, ME
    Sharkey, RM
    Behr, T
    Swayne, LC
    Dunn, R
    Siegel, J
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (09) : 1504 - 1510
  • [2] Radioimmunotherapy in patients with CEA-producing cancers and small-volume disease using I-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')(2)
    Juweid, M
    Sharkey, RM
    Swayne, LC
    Behr, TM
    Dunn, R
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 735 - 735
  • [3] Fractionated radioimmunotherapy using low doses of iodine 131 labeled anti-CEA monoclonal antibody after tumor volume reduction
    田嘉禾
    丁勇
    张锦明
    曹丽敏
    尹大一
    中华医学杂志(英文版), 2000, (01) : 53 - 58
  • [4] Fractionated radioimmunotherapy using low doses of iodine 131 labeled anti-CEA monoclonal antibody after tumor volume reduction
    田嘉禾
    丁勇
    张锦明
    曹丽敏
    尹大一
    Chinese Medical Journal, 2000, (01)
  • [5] Fractionated radioimmunotherapy using low doses of iodine-131 labeled anti-CEA monoclonal antibody after tumor volume reduction
    Tian, JH
    Ding, Y
    Zhang, JM
    Cao, LM
    Yin, DY
    CHINESE MEDICAL JOURNAL, 2000, 113 (01) : 53 - 58
  • [6] Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab′)2 after resection of liver metastases from colorectal cancer
    Ychou, M
    Faurous, P
    Saint-Aubert, B
    Rouanet, P
    Quenet, F
    Robert, B
    Guerreau, D
    Saccavini, JC
    Mach, JP
    Artus, JC
    Pelegrin, A
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (01) : 62 - 62
  • [7] Phase I/II trial of two step radioimmunotherapy in medullary thyroid cancer (MTC) using bispecific anti-CEA/anti-DTPA-In antibody and iodine-131-labeled bivalent hapten.
    Bodere, FK
    Bardet, S
    Vuillez, JP
    Bardies, M
    Gautherot, E
    Rouvier, E
    Barbet, J
    Chatal, JF
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 246P - 246P
  • [8] Radioimmunotherapy of small-volume disease of metastatic colorectal cancer: Results of a phase II trial with the iodine-131-labeled humanized anti-carcinoembryonic antigen antibody hMN-14 (Retraction of vol 94, pg 1373, 2002)
    Behr, T. M.
    Liersch, T.
    Greiner-Bechert, L.
    Griesinger, F.
    Behe, M.
    Markus, P. M.
    Gratz, S.
    Angerstein, C.
    Brittinger, G.
    Becker, H.
    Goldenberg, D. M.
    Becker, W.
    CANCER, 2015, 121 (13) : 2290 - 2290
  • [9] Radioimmunotherapy of LS174T colon carcinoma in nude mice using an iodine-131-labeled bivalent hapten combined with an anti-CEA x anti-indium-DTPA bispecific antibody.
    Gautherot, E
    Bouhou, J
    Loucif, E
    Manetti, C
    Martin, M
    LeDoussal, JW
    Rouvier, E
    Barbet, J
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 18 - 18
  • [10] Phase-I/II radio-immunotherapy study with iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab′)2 in patients with non-resectable liver metastases from colorectal cancer
    Ychou, M
    Pelegrin, A
    Faurous, P
    Robert, B
    Saccavini, JC
    Guerreau, D
    Rossi, JF
    Fabbro, M
    Buchegger, F
    Mach, JP
    Artus, JC
    INTERNATIONAL JOURNAL OF CANCER, 1998, 75 (04) : 615 - 619
12